scholarly journals Antimicrobial Bacillus: Metabolites and Their Mode of Action

Antibiotics ◽  
2022 ◽  
Vol 11 (1) ◽  
pp. 88
Author(s):  
Charlie Tran ◽  
Ian E. Cock ◽  
Xiaojing Chen ◽  
Yunjiang Feng
Keyword(s):  
World Health ◽  
The European Union ◽  
Feed Conversion ◽  
Growth Promoters ◽  
Agricultural Industry ◽  
Antibiotic Growth Promoters ◽  
Health Organization ◽  
Harsh Conditions ◽  
Spore Forming Bacteria ◽  
Upper Gastrointestinal

The agricultural industry utilizes antibiotic growth promoters to promote livestock growth and health. However, the World Health Organization has raised concerns over the ongoing spread of antibiotic resistance transmission in the populace, leading to its subsequent ban in several countries, especially in the European Union. These restrictions have translated into an increase in pathogenic outbreaks in the agricultural industry, highlighting the need for an economically viable, non-toxic, and renewable alternative to antibiotics in livestock. Probiotics inhibit pathogen growth, promote a beneficial microbiota, regulate the immune response of its host, enhance feed conversion to nutrients, and form biofilms that block further infection. Commonly used lactic acid bacteria probiotics are vulnerable to the harsh conditions of the upper gastrointestinal system, leading to novel research using spore-forming bacteria from the genus Bacillus. However, the exact mechanisms behind Bacillus probiotics remain unexplored. This review tackles this issue, by reporting antimicrobial compounds produced from Bacillus strains, their proposed mechanisms of action, and any gaps in the mechanism studies of these compounds. Lastly, this paper explores omics approaches to clarify the mechanisms behind Bacillus probiotics.

scholarly journals Potassium Diformate : A New Alternative To Antibiotic Growth Promoters

1970 ◽  
Vol 37 (2) ◽  
pp. 99-105 ◽  
Author(s):  
R Chowdhury ◽  
MN Haque ◽  
KMS Islam ◽  
MJ Khan
Keyword(s):  
Growth Promoter ◽  
The European Union ◽  
Feed Conversion ◽  
Growth Promoters ◽  
Main Mode ◽  
Special Effect ◽  
Growing Pig ◽  
Antibiotic Growth Promoters ◽  
Inclusion Level ◽  
Growth Promoting

Potassium diformate (Formi) is odorless, low-corrosive and easy to handle. The European Union (EU) has approved it as non-antibiotic growth promoter, for use in non ruminant feeds. Maximum inclusion level of potassium diformate is 1.8% as registered by the European authorities which can improve weight gain up to 14%. Potassium diformate contains the active ingredients free formic acid as well as formate has the strong anti microbial effect in stomach and also in duodenum. Potassium diformate with its growth promoting and health enhancing effect has proven to be an alternative to antibiotic growth promoters. Its special effect on the micro flora is regarded as the main mode of action. 1.8% potassium diformate in growing pig diets also significantly increase Feed intake and feed conversion ratio was significantly improved where growing pig diets was supplemented with 1.8% potassium diformate. It was also reduced pH in the stomach and duodenum. potassium diformate 0.9% significantly reduced the pH of duodenal digesta. DOI: http://dx.doi.org/10.3329/bjas.v37i2.9887 BJAS 2008; 37(2): 99-105

scholarly journals A Review of the Effects and Production of Spore-Forming Probiotics for Poultry

Animals ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 1941
Author(s):  
Igor V. Popov ◽  
Ammar Algburi ◽  
Evgeniya V. Prazdnova ◽  
Maria S. Mazanko ◽  
Vladimir Elisashvili ◽  
...  
Keyword(s):  
Health Promotion ◽  
One Health ◽  
Mechanisms Of Action ◽  
Human Medicine ◽  
Poultry Industry ◽  
Growth Promoters ◽  
Wide Range ◽  
Antibiotic Growth Promoters ◽  
Spore Forming Bacteria ◽  
Unique Ability

One of the main problems in the poultry industry is the search for a viable replacement for antibiotic growth promoters. This issue requires a “one health” approach because the uncontrolled use of antibiotics in poultry can lead to the development of antimicrobial resistance, which is a concern not only in animals, but for humans as well. One of the promising ways to overcome this challenge is found in probiotics due to their wide range of features and mechanisms of action for health promotion. Moreover, spore-forming probiotics are suitable for use in the poultry industry because of their unique ability, encapsulation, granting them protection from the harshest conditions and resulting in improved availability for hosts’ organisms. This review summarizes the information on gastrointestinal tract microbiota of poultry and their interaction with commensal and probiotic spore-forming bacteria. One of the most important topics of this review is the absence of uniformity in spore-forming probiotic trials in poultry. In our opinion, this problem can be solved by the creation of standards and checklists for these kinds of trials such as those used for pre-clinical and clinical trials in human medicine. Last but not least, this review covers problems and challenges related to spore-forming probiotic manufacturing.

scholarly journals The politics of crisis management by regional and international organizations in fighting against a global pandemic: the member states at a crossroads

2021 ◽  
pp. 002085232098451
Author(s):  
Steven Van Hecke ◽  
Harald Fuhr ◽  
Wouter Wolfs
Keyword(s):  
Crisis Management ◽  
International Organizations ◽  
Governance Structure ◽  
Added Value ◽  
World Health ◽  
The European Union ◽  
Member States ◽  
Global Pandemic ◽  
Turbulent Times ◽  
Health Organization

Despite new challenges like climate change and digitalization, global and regional organizations recently went through turbulent times due to a lack of support from several of their member states. Next to this crisis of multilateralism, the COVID-19 pandemic now seems to question the added value of international organizations for addressing global governance issues more specifically. This article analyses this double challenge that several organizations are facing and compares their ways of managing the crisis by looking at their institutional and political context, their governance structure, and their behaviour during the pandemic until June 2020. More specifically, it will explain the different and fragmented responses of the World Health Organization, the European Union and the International Monetary Fund/World Bank. With the aim of understanding the old and new problems that these international organizations are trying to solve, this article argues that the level of autonomy vis-a-vis the member states is crucial for understanding the politics of crisis management. Points for practitioners As intergovernmental bodies, international organizations require authorization by their member states. Since they also need funding for their operations, different degrees of autonomy also matter for reacting to emerging challenges, such as the COVID-19 pandemic. The potential for international organizations is limited, though through proactive and bold initiatives, they can seize the opportunity of the crisis and partly overcome institutional and political constraints.

scholarly journals Mental healthcare in Hungary: contradictions and possibilities

2010 ◽  
Vol 7 (2) ◽  
pp. 36-38 ◽  
Author(s):  
Tamás Kurimay
Keyword(s):  
Health Spending ◽  
Mental Healthcare ◽  
World Health ◽  
Minority Population ◽  
Official Language ◽  
The European Union ◽  
Middle Income ◽  
The Republic ◽  
Health Organization ◽  
The Uk

The Republic of Hungary is a landlocked country of 93000 km2 in central Europe; it is bordered by Austria, Slovakia, Ukraine, Romania, Serbia, Croatia and Slovenia. Its official language is Hungarian. Hungary joined the European Union (EU) in 2004. About 90% of the population of c. 10 million is ethnically Hungarian, with Roma comprising the largest minority population (6–8%). Currently classified as a middle-income country with a gross domestic product (GDP) of $191.7 billion (2007 figure), Hungary's total health spending accounted for 7.4% of GDP in 2007, less than the average of 8.9% among member states of the Organisation for Economic Co-operation and Development (OECD, 2009). The proportion of the total health budget for mental health is 5.1%, which is low when compared with, for instance, the UK (England and Wales 13.8%, Scotland 9.5%) (World Health Organization, 2008, p. 118, Fig. 8.1).

scholarly journals Global Governance of Anti-microbial Resistance: A Legal and Regulatory Toolkit

2020 ◽  
pp. 401-420
Author(s):  
Calvin W. L. Ho ◽  
Tsung-Ling Lee
Keyword(s):  
Public Health ◽  
System Approach ◽  
Action Plan ◽  
World Health ◽  
Health Concern ◽  
Global Public Health ◽  
Agricultural Industry ◽  
Treatment And Prevention ◽  
Global Action ◽  
Health Organization

Abstract Recognizing that antimicrobial resistance (AMR) poses a serious threat to global public health, the World Health Organization (WHO) has adopted a Global Action Plan (GAP) at the May 2015 World Health Assembly. Underscoring that systematic misuse and overuse of drugs in human medicine and food production is a global public health concern, the GAP-AMR urges concerted efforts across governments and private sectors, including pharmaceutical industry, medical professionals, agricultural industry, among others. The GAP has a threefold aim: (1) to ensure a continuous use of effective and safe medicines for treatment and prevention of infectious diseases; (2) to encourage a responsible use of medicines; and (3) to engage countries to develop their national actions on AMR in keeping with the recommendations. While the GAP is a necessary step to enable multilateral actions, it must be supported by effective governance in order to realize the proposed aims. This chapter has a threefold purpose: (1) To identify regulatory principles embedded in key WHO documents relating to AMR and the GAP-AMR; (2) To consider the legal and regulatory actions or interventions that countries could use to strengthen their regulatory lever for AMR containment; and (3) To highlight the crucial role of the regulatory lever in enabling other levers under a whole-of-system approach. Effective AMR containment requires a clearer understanding of how the regulatory lever could be implemented or enabled within health systems, as well as how it underscores and interacts with other levers within a whole-of-system approach.

scholarly journals Pathways to clean hands: highlights of successful hand hygiene implementation strategies in Europe

2010 ◽  
Vol 15 (18) ◽  
Author(s):  
A P Magiorakos ◽  
E Leens ◽  
V Drouvot ◽  
L May-Michelangeli ◽  
C Reichardt ◽  
...  
Keyword(s):  
Hand Hygiene ◽  
Implementation Strategies ◽  
World Health ◽  
Surveillance Systems ◽  
The European Union ◽  
Hygiene Practices ◽  
Governmental Support ◽  
Hygiene Compliance ◽  
Health Organization ◽  
Healthcare Associated

Hand hygiene is the most effective way to stop the spread of microorganisms and to prevent healthcare-associated infections (HAI). The World Health Organization launched the First Global Patient Safety Challenge - Clean Care is Safer Care - in 2005 with the goal to prevent HAI globally. This year, on 5 May, the WHO’s initiative SAVE LIVES: Clean Your Hands, which focuses on increasing awareness of and improving compliance with hand hygiene practices, celebrated its second global day. In this article, four Member States of the European Union describe strategies that were implemented as part of their national hand hygiene campaigns and were found to be noteworthy. The strategies were: governmental support, the use of indicators for hand hygiene benchmarking, developing national surveillance systems for auditing alcohol-based hand rub consumption, ensuring seamless coordination of processes between health regions in countries with regionalised healthcare systems, implementing the WHO's My Five Moments for Hand Hygiene, and auditing of hand hygiene compliance.

Patient Safety Concerns among Emergency Medical Staff and Patients

2013 ◽  
Vol 1 (1) ◽  
pp. 29-52
Author(s):  
Pi-Fang Hsu ◽  
Wen-Chun Tsai ◽  
Chia-Wen Tsai
Keyword(s):  
Patient Safety ◽  
Emergency Departments ◽  
Medical Staff ◽  
World Health ◽  
The European Union ◽  
Department Of Health ◽  
Perceptions And Attitudes ◽  
The World ◽  
Health Organization

Recently, much of the world, including the World Health Organization, the European Union and many North American countries, have emphasized patient safety. Around the same time, Taiwan’s Department of Health (DOH) devoted a significant amount of resources to better the quality of medical treatment for their patients. This study explores perceptions of and attitudes towards patient safety among medical staff and patients in emergency departments. Analysis results indicate that medical staff and patients significantly differ in perceptions and attitudes. Results of this study provide a valuable reference for governmental authorities and hospital managers in formulating policies aimed at clarifying perceptions and attitudes regarding patient safety among medical staff and patients in emergency departments.

Genetic Material and Sequence Data to Protect Global Health in the Light of Pandemic Outbreaks: Mapping the Legal Landscape under European and International Law

2020 ◽  
Vol 27 (3) ◽  
pp. 232-241
Author(s):  
Claudia Seitz
Keyword(s):  
Global Health ◽  
International Law ◽  
Sequence Data ◽  
Influenza Pandemic ◽  
Genetic Material ◽  
World Health ◽  
The European Union ◽  
Corona Virus ◽  
Health Organization ◽  
The Eu

Abstract The current pandemic outbreak of corona virus SARS-CoV-2 shows the need for comprehensive European cooperation in drug development and the importance of genetic material and sequence data in research concerning this unknown disease. As corona virus SARS-CoV-2 is spreading across Europe and worldwide, national authorities and the European Union (EU) institutions do their utmost to address the pandemic and accelerate innovation to protect global health. In order to be prepared and to be able to respond immediately to serious epidemic and pandemic diseases, the EU has already adopted the Decision No (EU) 1082/2013 on serious cross-border threats to health. The World Health Organization (WHO) has established a global system to collect genetic material and information to protect a global influenza pandemic outbreak. The article describes the current legal landscape under EU and international law.

The Institutional Active Aging Paradigm in Europe (2002–2015)

2019 ◽  
Vol 60 (3) ◽  
pp. 406-415 ◽  
Author(s):  
Raúl López-López ◽  
Mariano Sánchez
Keyword(s):  
World Health ◽  
Critical Examination ◽  
Active Aging ◽  
The European Union ◽  
Reductive Treatment ◽  
Health Organization ◽  
Ideal Framework ◽  
Point Of Departure ◽  
The Eu ◽  
The Ideal

Abstract Background and Objectives The paradigm of active aging has been slowly gaining ground in Europe as the ideal framework for public policy and for responding to the population’s aging. Taking the work by Rune Ervik as its point of departure, this article updates his conclusions on conceptualizations and policies of active aging by performing a study of the institutional discourses in the matter produced by the World Health Organization (WHO), the Organization for Economic Cooperation and Development (OECD), and the European Union (EU). Methods A corpus of 15 WHO, OECD, and EU documents published in the period 2002–2015 and tackling active aging were analyzed qualitatively through a combination of content and thematic analysis, based on a scheme integrated by deductive and inductive iterative manual and computerized codification. Results The institutional discourses on active aging analyzed have not changed dramatically in the period considered. However, a divergent path has emerged regarding the accent placed on participation and contribution in the construction of the paradigm: the more socially productive and health-oriented WHO discourse is slowly separating from the more economically productive and labor-oriented discourses of the EU and OECD. Discussion and Implications The institutional paradigm on active aging is evolving into a reductive treatment of a phenomenon that is multidimensional. International institutions and researchers should pay closer attention and forge a path toward an honest and critical examination of the real conditions and expectations of older people concerning the discursive and practical proposals of active aging, in all its different forms.

scholarly journals A direct fed microbial containing a combination of three-strain Bacillus sp. can be used as an alternative to feed antibiotic growth promoters in broiler production

2013 ◽  
Vol 2 ◽  
Author(s):  
Yueming Dersjant-Li ◽  
A. Awati ◽  
C. Kromm ◽  
C. Evans
Keyword(s):  
Large Scale ◽  
Production Efficiency ◽  
Total Mortality ◽  
Commercial Production ◽  
Growth Promoter ◽  
Feed Conversion ◽  
Growth Promoters ◽  
Strain Combination ◽  
Bacillus Spp ◽  
Antibiotic Growth Promoters

SummaryThe objective of the study was to test the effect of a direct fed microbial (DFM) on the performance of broilers compared to an antibiotic growth promoter under large scale, commercial production settings. Three dietary treatments were tested in a completely randomized design including: 1) a control (C) diet containing 500 FTU/kg phytase and a mixture of xylanase, amylase, protease ; 2) C+ a specific three-strain combination of Bacillus spp. (DFM) and 3) C+ bacitracin methylene disalicylate (BMD). Six, similar commercial broiler houses (15,300 birds per house) were used to give two replicate houses per treatment. The birds (Hubbard x Cobb500) were fed pelleted and crumbled diets ad libitum throughout the 44 day trial period. Due to the large scale, commercial nature of the trial, no significant differences were observed in production parameters among treatments, except that DFM treatment resulted in significantly lower mortality numbers in the last two days (43 to 44d) compared to the control. However, the DFM treatment group showed numerically higher live bodyweight, lower feed conversion ratio (corrected for body weight and mortality) and lower total mortality weight compared to either the control or BMD groups, resulting in an improved production efficiency factor. When compared to control, using DFM resulted in a gross benefit of US$ 0.06 /bird, while using BMD was not cost effective. In conclusion, DFM containing a three-strain combination of Bacillus spp. may be used as an alternative to antibiotic growth promoters, resulting in economic benefit under commercial production settings in broilers fed commercial diets.

Sign in / Sign up

Export Citation Format

Share Document